Caris Life Sciences (CAI) Exchange Rate Effect (2024 - 2026)
Caris Life Sciences (CAI) posted quarterly Exchange Rate Effect of -$10000.0 for Q1 2026, down 350.0% year-over-year from $4000.0 in Q1 2025, and up 65.52% quarter-over-quarter from -$29000.0 in Q4 2025.
Powered by 
Analysis
Caris Life Sciences (CAI) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Caris Life Sciences' Exchange Rate Effect history runs 3 years deep, the most recent figure standing at -$10000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 350.0% year-over-year to -$10000.0; the TTM figure through Mar 2026 stood at $116000.0 (changed N/A YoY), while the FY2025 annual figure was $130000.0, up 3350.0% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$10000.0, up from -$29000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $93000.0 in Q2 2025, with the low at -$29000.0 in Q4 2025.
- The 3-year median for Exchange Rate Effect is -$1000.0 (2024), against an average of $14714.3.
- Peak annual rise in Exchange Rate Effect reached 487.5% in 2025, while the deepest fall reached 2800.0% in 2025.
- Caris Life Sciences' Exchange Rate Effect stood at -$1000.0 in 2024, then sank by 2800.0% to -$29000.0 in 2025, then jumped by 65.52% to -$10000.0 in 2026.
- Business Quant data shows CAI's Exchange Rate Effect at -$10000.0 in Q1 2026, -$29000.0 in Q4 2025, and $62000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Caris Life Sciences | 7.08 Bn | 6.28 Bn | 182.38 Mn | -27,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -27,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Sep 30, 2025 | 62,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | -16,000.00 |